콘텐츠로 건너뛰기
주식/증권 📉 부정적

Why You Should Think About Eli Lilly Stock Differently Now

요약

Eli Lilly (LLY) stock is priced at 38.7 times earnings, compared with 21.5 for the S&P 500. Investors evaluating that valuation should weigh what drives it, especially since the company's priorities have shifted. In late 2024, management opened its earnings call by detailing how many doses of its weight-loss and diabetes drugs it could manufacture. Today, the primary focus has broadened considerably beyond factory output. So what is it.